Evaluación del trastorno de ansiedad generalizada
GAD-7
Authored by Patient infomatics teamPublicado originalmente 9 de septiembre de 2025
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
Profesionales Médicos
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Ansiedad article more useful, or one of our other artículos de salud.
En este artículo:
This easy-to-use self-administered patient questionnaire is used as a screening tool and severity measure for generalised anxiety disorder (GAD).12
Continúa leyendo abajo
Generalised Anxiety Disorder Questionnaire (GAD-7)
The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions.
Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.
Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD. It is moderately good at screening three other common anxiety disorders - panic disorder (sensitivity 74%, specificity 81%), social anxiety disorder (sensitivity 72%, specificity 80%) and post-traumatic stress disorder (sensitivity 66%, specificity 81%).3
Note about credits
Volver al contenidoThe copyright for the GAD-7 was formerly held with Pfizer, who provided the educational grant for Drs Spitzer, Williams and Kroenke who originally designed it. In 2010, Pfizer made available both the PHQ-9 and the GAD-7 without copyright restriction and at no charge. As such, no permission is required to reproduce, translate, display or distribute the GAD-7.
Lecturas adicionales y referencias
- Swinson RP; The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med. 2006 Dec 11(6):184.
- Spitzer RL, Kroenke K, Williams JB, et al; A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22 166(10):1092-7.
- Kroenke K, Spitzer RL, Williams JB, et al; Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6 146(5):317-25.
Continúa leyendo abajo
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
9 de septiembre de 2025 | Publicado originalmente
Escrito por:
Equipo de informática del paciente

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita